Sorted By:


Burden on Patients: Preserving the ‘New Normal’ for Patients with Rheumatoid Arthritis

PhRMA  |  Blog Post

Harvey told the story of a young mother in her 30s whose high copays and deductibles mean she cannot afford the advanced treatments she needs to effectively treat her disease.

5 Things to Know About the CMS Part D Data Release

PhRMA  |  Blog Post

Competition and rebates have been significant in keeping Part D costs $349 billion lower than initial ten-year projections and keeping costs and premiums low for beneficiaries.

Medicare Monday: New Video - How Patients Benefit from Medicare Part D

PhRMA  |  Blog Post

We hope you’ll follow all the Medicare festivities with us throughout the month.

New PhRMA report: New medicines in development for autoimmune diseases offer patients hope for brighter futures

PhRMA  |  Blog Post

A new PhRMA report, “Medicines in Development for Autoimmune Diseases,” released in partnership with the Lupus Foundation of America, demonstrates how the more than 300 medicines currently in development offer patients with diseases such as arthritis, Crohn’s disease, lupus, type 1 diabetes and multiple sclerosis the opportunity to live longer, healthier lives through innovation.

Collaboration is What Will Help Drive New Successes for the Rare Disease Community

PhRMA  |  Blog Post

Our annual RARE Patient Advocacy Summit also continues to increase in both participation and demand for content – expanding this year to a 1 1/2 day event with more than 400 projected attendees.

America’s biopharmaceutical industry is central to diverse R&D ecosystem

PhRMA  |  Blog Post

  While government agencies like the National Institutes of Health and academic institutions  conduct important basic research to help understand diseases and how they may be effectively treated, Dr.

Strong IP is propelling innovation and saving lives

PhRMA  |  Blog Post

    The technological and innovative discoveries that are driving improved patient care are due to the spirit of risk taking and outside-the-box thinking encouraged in labs across America.

Team PhRMA Raises $100,000 for Leukemia/Lymphoma Research

PhRMA  |  Press Release

A new report released by PhRMA yesterday shows that America’s biopharmaceutical research companies are developing more than 240 medicines to treat leukemia, lymphoma, and other blood cancers.

2016 BCI Survey: A pro-innovation environment is essential for biopharmaceutical investment

PhRMA  |  Blog Post

BCI Overall Results Newcomer Markets Mature Markets Source: Pugatch Consilium (2016) In its third edition, the BCI Survey is a global executive opinion survey and index of economies’ biomedical investment-attractiveness created by Pugatch Consilium and commissioned by PhRMA.

Paying for Personalized Medicine: Protecting the Future of Patient-Centered Cancer Care

PhRMA  |  Blog Post

At a time of unprecedented scientific breakthroughs in oncology, personalized medicine is enabling more accurate diagnoses and more targeted treatments, increasing the overall efficiency and effectiveness of cancer care.

Personalized Medicine: The next health frontier

PhRMA  |  Blog Post

Photo credit: The Hill The biopharmaceutical industry does its part through deep, consistent investment.

Direct-to-consumer advertising makes doctors and patients stronger partners

PhRMA  |  Blog Post

If it had, Times readers would have read of FDA’s conclusion that “[b]y and large, DTC advertising seems to increase [patients’] awareness of conditions and treatments, motivate questions for the healthcare provider, and help patients ask better questions.

Medicare Monday: It’s important to shop around, even if your premium is decreasing next year

PhRMA  |  Blog Post

Another plan had a slightly higher monthly premium but much lower total annual costs, saving my grandfather nearly $300 next year.

Health coverage resources in Spanish

PhRMA  |  Blog Post

The new page has helpful resources for understanding how health insurance works and what to expect from your coverage.

Medicare Monday: How Part D Helps Parkinson’s Patients

PhRMA  |  Blog Post

Consider this: when patients prematurely discontinue their medication, it costs the U.S. economy an estimated $100 billion to $300 billion annually.

New Chart Pack: Advancing Innovative Treatment Options for Patients Through Personalized Medicine

PhRMA  |  Blog Post

There are nearly 140 FDA-approved medicines on the market with biomarker information in the label, and in 2014 alone 1 in 5 FDA approvals were for personalized medicines.

3 Reasons Patient Engagement is the Backbone of Scientific Discovery

PhRMA  |  Blog Post

As John points out, patient engagement is critical to the research and development process for three central reasons: First, industry scientists need to understand patient perspectives on the diseases they are working to treat and cure; second, critical to the development of new therapies is

New Research: Access and quality implications of CMS proposed Part B model

PhRMA  |  Blog Post

These concerns that the Part B Drug Payment Model could have serious consequences for patient access to appropriate care were raised by over 300 stakeholders.

Research doesn’t end on a medicine’s approval

PhRMA  |  Blog Post

Post-approval research utilizes data produced in the practice of medicine, including from patients, providers and payers.

Who is Making Decisions About Your Health Care?

PhRMA  |  Blog Post

Even though insurers are not involved in your direct care or privy to why your doctor prescribed one medicine over another, many try to limit the use of certain prescriptions to control health care costs and steer patients to medicines insurers prefer.

Medicare Monday: More Medicines in Development for Older Americans

PhRMA  |  Blog Post

Medicare Part D is a competitive marketplace that allows older Americans to access needed medicines.

Welcome news in two high-profile cancer battles

PhRMA  |  Blog Post

President Carter and Governor Hogan have spoken openly about their treatment plans, which included surgery, radiation, chemotherapy and new cutting-edge immunotherapy treatments.

The ABCs of Health Coverage

PhRMA  |  Blog Post is designed to educate consumers about the ABCs of health coverage and access to prescription medicines.

Because One Day Isn't Enough

PhRMA  |  Blog Post

So, I imagine my $400 or so (I no longer remember the exact amount) probably didn't get too far.

Loretta Shares a Story of Hope in the Face of Her Cancer Diagnosis

PhRMA  |  Blog Post

Annually, 580,000 Americans lose their battle with cancer, equating to 1,600 deaths daily.

You have reviewed the first 350 results out of 429. Each page contains 25 results. You're on page 14.

prev 13 14 15 16 17 18 next